Platelet-Neutrophil Association in NETs-Rich Areas in the Retrieved AIS Patient Thrombi.
AIS
HMGB1
NETs
fibrin
leukocytes
neutrophils
platelets
stroke
t-PA
von Willebrand factor
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
21 Nov 2022
21 Nov 2022
Historique:
received:
04
10
2022
revised:
08
11
2022
accepted:
10
11
2022
entrez:
26
11
2022
pubmed:
27
11
2022
medline:
30
11
2022
Statut:
epublish
Résumé
Histological structure of thrombi is a strong determinant of the outcome of vascular recanalization therapy, the only treatment option for acute ischemic stroke (AIS) patients. A total of 21 AIS patients from this study after undergoing non-enhanced CT scan and multimodal MRI were treated with mechanical stent-based and manual aspiration thrombectomy, and thromboembolic retrieved from a cerebral artery. Complementary histopathological and imaging analyses were performed to understand their composition with a specific focus on fibrin, von Willebrand factor, and neutrophil extracellular traps (NETs). Though distinct RBC-rich and platelet-rich areas were found, AIS patient thrombi were overwhelmingly platelet-rich, with 90% of thrombi containing <40% total RBC-rich contents (1.5 to 37%). Structurally, RBC-rich areas were simple, consisting of tightly packed RBCs in thin fibrin meshwork with sparsely populated nucleated cells and lacked any substantial von Willebrand factor (VWF). Platelet-rich areas were structurally more complex with thick fibrin meshwork associated with VWF. Plenty of leukocytes populated the platelet-rich areas, particularly in the periphery and border areas between platelet-rich and RBC-rich areas. Platelet-rich areas showed abundant activated neutrophils (myeloperoxidase+ and neutrophil-elastase+) containing citrullinated histone-decorated DNA. Citrullinated histone-decorated DNA also accumulated extracellularly, pointing to NETosis by the activated neutrophils. Notably, NETs-containing areas showed strong reactivity to VWF, platelets, and high-mobility group box 1 (HMGB1), signifying a close interplay between these components.
Identifiants
pubmed: 36430952
pii: ijms232214477
doi: 10.3390/ijms232214477
pmc: PMC9694992
pii:
doi:
Substances chimiques
von Willebrand Factor
0
Histones
0
Fibrin
9001-31-4
DNA
9007-49-2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Medical Research Council (MRC) Hamad Medical Corporation (HMC) Doha, Qatar
ID : IRGC-02-SI-029
Références
J Exp Med. 2012 Apr 9;209(4):819-35
pubmed: 22451716
J Clin Invest. 2015 Dec;125(12):4638-54
pubmed: 26551681
Thromb Haemost. 1999 Mar;81(3):400-6
pubmed: 10102469
J Clin Invest. 2000 Mar;105(6):783-91
pubmed: 10727447
Arterioscler Thromb Vasc Biol. 2000 Jun;20(6):1661-7
pubmed: 10845886
Clin Rev Allergy Immunol. 2021 Oct;61(2):194-211
pubmed: 32740860
Thromb Haemost. 2001 Jul;86(1):189-97
pubmed: 11487007
Lancet. 2016 Apr 23;387(10029):1723-31
pubmed: 26898852
Blood. 2013 Jun 20;121(25):5088-97
pubmed: 23589671
Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
J Exp Med. 2006 Mar 20;203(3):767-76
pubmed: 16533881
Science. 1980 Feb 1;207(4430):541-3
pubmed: 7352265
Circulation. 2001 Dec 4;104(23):2855-64
pubmed: 11733407
Curr Opin Hematol. 2003 Mar;10(2):142-9
pubmed: 12579041
Blood. 2014 May 1;123(18):2768-76
pubmed: 24366358
PLoS Pathog. 2009 Oct;5(10):e1000639
pubmed: 19876394
Nat Rev Microbiol. 2007 Aug;5(8):577-82
pubmed: 17632569
Blood. 2009 Nov 26;114(23):4883-5
pubmed: 19726719
Platelets. 2021 Apr 3;32(3):314-324
pubmed: 32896192
J Neuroradiol. 2015 Apr;42(2):86-92
pubmed: 24560545
J Biol Chem. 2001 Nov 2;276(44):41059-63
pubmed: 11557746
Nat Med. 2008 Sep;14(9):949-53
pubmed: 18690244
Annu Rev Fluid Mech. 2015 Jan 1;47:377-403
pubmed: 26236058
Neurology. 2015 Feb 10;84(6):623-5
pubmed: 25666629
Stroke. 2006 Aug;37(8):2086-93
pubmed: 16794209
Arterioscler Thromb Vasc Biol. 2014 Jul;34(7):1382-9
pubmed: 24790143
FASEB J. 2003 Aug;17(11):1490-2
pubmed: 12824298
J Thromb Haemost. 2016 May;14(5):918-30
pubmed: 26929147
Ann N Y Acad Sci. 1992 Dec 4;667:70-80
pubmed: 1285024
Thromb Haemost. 2008 Feb;99(2):343-51
pubmed: 18278184
J Clin Invest. 2022 May 16;132(10):
pubmed: 35358095
Curr Biol. 2006 Feb 21;16(4):396-400
pubmed: 16488874
Front Immunol. 2016 Jul 06;7:271
pubmed: 27458459
J Thromb Haemost. 2014 Dec;12(12):2074-88
pubmed: 25163512
Curr Opin Microbiol. 2007 Feb;10(1):52-6
pubmed: 17208512
Blood. 1998 Jun 15;91(12):4397-418
pubmed: 9616133
PLoS One. 2014 Feb 11;9(2):e88882
pubmed: 24523944
Thromb Res. 2007;120 Suppl 1:S5-9
pubmed: 17493665
Stroke. 2016 Jul;47(7):1864-71
pubmed: 27197854
Exp Transl Stroke Med. 2015 Jan 27;7:2
pubmed: 25657829
Blood. 2016 May 12;127(19):2337-45
pubmed: 26929275
Circulation. 1989 Apr;79(4):920-8
pubmed: 2494006
AJNR Am J Neuroradiol. 2015 Sep;36(9):1756-62
pubmed: 26159515
Sci Rep. 2018 Feb 1;8(1):2068
pubmed: 29391442
Haematologica. 2020 Jan 31;105(2):498-507
pubmed: 31048352
Cell. 1998 Sep 4;94(5):657-66
pubmed: 9741630
Stroke. 2018 Mar;49(3):754-757
pubmed: 29438080
J Am Heart Assoc. 2020 Aug 4;9(15):e016534
pubmed: 32750304
Ann Neurol. 2017 Aug;82(2):223-232
pubmed: 28696508
Science. 2004 Mar 5;303(5663):1532-5
pubmed: 15001782
Clin Neuroradiol. 2016 Jun;26(2):189-97
pubmed: 25261075
Cardiovasc Hematol Disord Drug Targets. 2009 Mar;9(1):9-20
pubmed: 19275573
Neurology. 2018 Jun 5;90(23):1075
pubmed: 29866933
Stroke. 2011 May;42(5):1237-43
pubmed: 21393591
Blood. 2017 Oct 19;130(16):1795-1799
pubmed: 28811305
Atherosclerosis. 2014 May;234(1):102-7
pubmed: 24632509
Cell Death Discov. 2018 Jun 28;4:6
pubmed: 30062055
Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2415-9
pubmed: 12606706
Arterioscler Thromb Vasc Biol. 2007 Apr;27(4):728-39
pubmed: 17272754
Blood. 2012 Sep 6;120(10):2133-43
pubmed: 22837532
Nature. 2001 Oct 4;413(6855):488-94
pubmed: 11586351
Nat Med. 2007 Apr;13(4):463-9
pubmed: 17384648
Arterioscler Thromb Vasc Biol. 2011 Oct;31(10):2261-9
pubmed: 21799176
Ann N Y Acad Sci. 2013 Apr;1281:51-63
pubmed: 23317344
Blood. 2008 Mar 15;111(6):3070-80
pubmed: 18182576
Curr Opin Hematol. 2007 May;14(3):236-41
pubmed: 17414213
Blood. 2006 Mar 1;107(5):1943-50
pubmed: 16293606
Blood. 2014 May 22;123(21):3354-63
pubmed: 24553181
Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):1777-83
pubmed: 22652600
Stroke. 1993 Jan;24(1):35-41
pubmed: 7678184
Int J Mol Sci. 2022 Jan 26;23(3):
pubmed: 35163333
J Innate Immun. 2009;1(3):176-80
pubmed: 20375575
JAMA Neurol. 2015 Aug;72(8):928-34
pubmed: 26030910
Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15880-5
pubmed: 20798043
Cerebrovasc Dis. 2014;37(2):116-22
pubmed: 24435107
Stroke. 2012 Feb;43(2):599-606
pubmed: 22180250
Proc Natl Acad Sci U S A. 2006 Nov 7;103(45):16900-5
pubmed: 17075060
J Biol Chem. 2013 Mar 8;288(10):6946-56
pubmed: 23293023
Nat Rev Neurol. 2014 Mar;10(3):135-43
pubmed: 24514866
Curr Opin Hematol. 2021 Sep 1;28(5):301-307
pubmed: 34183536